Seizure prophylaxis in meningiomas: a systematic review and meta-analysis.

Autor:	Delgado-López PD; Servicio de Neurocirugía, Hospital Universitario de Burgos, Burgos, Spain. Electronic address: pedrodl@yahoo.com., Ortega-Cubero S; Servicio de Neurología, Hospital Universitario de Burgos, Burgos, Spain., González Bernal JJ; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain., Cubo-Delgado E; Servicio de Neurología, Hospital Universitario de Burgos, Burgos, Spain.
Jazyk:	angličtina
Zdroj:	Neurologia [Neurologia (Engl Ed)] 2023 May; Vol. 38 (4), pp. 291-302. Date of Electronic Publication: 2022 Jun 30.
DOI:	10.1016/j.nrleng.2022.03.002
Abstrakt:	Introduction: No formal indication currently exists for seizure prophylaxis in neurosurgical oncology patients. Neither have specific recommendations been made on the use of antiepileptic drugs (AED) in seizure-free patients with meningiomas scheduled for surgery. AEDs are generally prescribed on a discretionary basis, taking into consideration a range of clinical and radiological risk factors. We present a systematic review and meta-analysis exploring the effectiveness of antiepileptic prophylaxis in patients with meningioma and no history of seizures. Methods: We performed a systematic review of the PubMed/MEDLINE, Cochrane Central Register of Controlled Trials, Embase, and clinicaltrials.gov databases. Of a total of 4368 studies initially identified, 12 were selected for extraction of data and qualitative analysis. Based on the clinical data presented, we were only able to include 6 studies in the meta-analysis. We performed heterogeneity studies, calculated a combined odds ratio, evaluated publication bias, and conducted a sensitivity analysis. Results: AED prophylaxis in patients with meningioma and no history of seizures did not significantly reduce the incidence of post-operative seizures in comparison to controls (Mantel-Haenszel combined odds ratio, random effects model: 1.26 [95% confidence interval, 0.60-2.78]; 2041 patients). However, we are unable to establish a robust recommendation against this treatment due to the lack of prospective studies, the presence of selection bias in the studies reviewed, the likelihood of underestimation of seizure frequency during follow-up, and the strong influence of one study on the overall effect. Conclusions: Despite the limitations of this review, the results of the meta-analysis do not support the routine use of seizure prophylaxis in patients with meningioma and no history of seizures. (Copyright © 2022. Published by Elsevier España, S.L.U.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu